Showing results (791-800 of 1,395) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|January 8, 2025
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative ResectionJames Yu, Aiwu Ruth He, Mahmoud Ouf, et al.
JCO Precision Oncology|January 6, 2025
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial CancerToru Sakatani, Takayuki Sumiyoshi, Yuki Kita, et al.
JCO Precision Oncology|January 8, 2025
Clinical Outcomes and Molecular Profiling of Pancreatic Acinar Cell Carcinoma: A Retrospective StudyCody Eslinger, Bobak Seddighzadeh, Claire Yee, et al.
JCO Precision Oncology|January 9, 2025
Targeted Next-Generation Sequencing in Succinate Dehydrogenase-Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR PathwayCarlo María Cicala, Judit Matito, María Quindos, et al.
JCO Precision Oncology|March 13, 2025
Multiomics Identifies Potential Molecular Profiles Associated With Outcomes After BRAF-Targeted Therapy in Patients With BRAF V600E-Mutated Advanced Solid TumorsMartina Eriksen, Anne M Hansen, Annelaura B Nielsen, et al.
JCO Precision Oncology|December 6, 2024
Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast CancerArlene Chan, Jespal Gill, HuiJun Chih, et al.
JCO Precision Oncology|December 5, 2024
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 MutationsAlessandro Di Federico, Stefania Angelicola, Mariateresa Frascino, et al.
JCO Precision Oncology|November 20, 2024
CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A ReviewKevin J Contrera, Matthew E Spector, Liron Pantanowitz, et al.
JCO Precision Oncology|November 22, 2024
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK AlterationsKatherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari, et al.
JCO Precision Oncology|November 5, 2024
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 TrialGopa Iyer, Catherine M Tangen, Michal Sarfaty, et al.
Pageof 140